A detailed history of Northern Trust Corp transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Northern Trust Corp holds 812,335 shares of IART stock, worth $17.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
812,335
Previous 504,137 61.13%
Holding current value
$17.9 Million
Previous $14.7 Million 0.48%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$17.14 - $31.74 $5.28 Million - $9.78 Million
308,198 Added 61.13%
812,335 $14.8 Million
Q2 2024

Aug 14, 2024

SELL
$23.14 - $34.72 $668,537 - $1 Million
-28,891 Reduced 5.42%
504,137 $14.7 Million
Q1 2024

May 14, 2024

SELL
$33.4 - $45.2 $2.09 Million - $2.82 Million
-62,438 Reduced 10.49%
533,028 $18.9 Million
Q4 2023

Feb 13, 2024

SELL
$34.21 - $44.59 $894,317 - $1.17 Million
-26,142 Reduced 4.21%
595,466 $25.9 Million
Q3 2023

Nov 13, 2023

SELL
$37.8 - $45.97 $732,639 - $890,990
-19,382 Reduced 3.02%
621,608 $23.7 Million
Q2 2023

Aug 11, 2023

SELL
$37.95 - $58.98 $936,681 - $1.46 Million
-24,682 Reduced 3.71%
640,990 $26.4 Million
Q1 2023

May 15, 2023

SELL
$52.61 - $60.49 $690,243 - $793,628
-13,120 Reduced 1.93%
665,672 $38.2 Million
Q4 2022

Feb 13, 2023

SELL
$42.17 - $58.6 $114,069 - $158,513
-2,705 Reduced 0.4%
678,792 $38.1 Million
Q3 2022

Nov 14, 2022

BUY
$42.28 - $57.17 $1.45 Million - $1.96 Million
34,237 Added 5.29%
681,497 $28.9 Million
Q2 2022

Aug 12, 2022

SELL
$53.86 - $66.52 $756,517 - $934,339
-14,046 Reduced 2.12%
647,260 $35 Million
Q1 2022

May 13, 2022

SELL
$62.86 - $69.24 $648,715 - $714,556
-10,320 Reduced 1.54%
661,306 $42.5 Million
Q4 2021

Feb 08, 2022

SELL
$62.47 - $73.25 $806,862 - $946,097
-12,916 Reduced 1.89%
671,626 $45 Million
Q3 2021

Nov 15, 2021

SELL
$64.97 - $76.19 $1.24 Million - $1.45 Million
-19,023 Reduced 2.7%
684,542 $46.9 Million
Q2 2021

Aug 13, 2021

SELL
$66.79 - $76.63 $1.24 Million - $1.43 Million
-18,597 Reduced 2.58%
703,565 $48 Million
Q1 2021

May 12, 2021

BUY
$62.63 - $71.15 $1.28 Million - $1.45 Million
20,387 Added 2.91%
722,162 $49.9 Million
Q4 2020

Feb 11, 2021

BUY
$43.31 - $66.55 $2,208 - $3,394
51 Added 0.01%
701,775 $45.6 Million
Q3 2020

Nov 16, 2020

SELL
$43.33 - $51.72 $558,350 - $666,463
-12,886 Reduced 1.8%
701,724 $33.1 Million
Q2 2020

Aug 14, 2020

BUY
$41.42 - $55.57 $418,259 - $561,145
10,098 Added 1.43%
714,610 $33.6 Million
Q1 2020

May 14, 2020

BUY
$36.67 - $61.04 $1.05 Million - $1.74 Million
28,532 Added 4.22%
704,512 $31.5 Million
Q4 2019

Feb 14, 2020

BUY
$55.73 - $62.49 $704,204 - $789,623
12,636 Added 1.9%
675,980 $39.4 Million
Q3 2019

Nov 13, 2019

SELL
$53.29 - $64.59 $1.16 Million - $1.41 Million
-21,754 Reduced 3.18%
663,344 $39.8 Million
Q2 2019

Aug 13, 2019

BUY
$46.45 - $55.85 $801,819 - $964,082
17,262 Added 2.58%
685,098 $38.3 Million
Q1 2019

May 13, 2019

BUY
$42.97 - $57.33 $2.58 Million - $3.45 Million
60,122 Added 9.89%
667,836 $37.2 Million
Q4 2018

Feb 12, 2019

BUY
$42.62 - $64.51 $289,773 - $438,603
6,799 Added 1.13%
607,714 $27.4 Million
Q3 2018

Nov 14, 2018

SELL
$57.63 - $65.87 $3.15 Million - $3.61 Million
-54,745 Reduced 8.35%
600,915 $39.6 Million
Q2 2018

Sep 18, 2018

SELL
$54.05 - $67.23 $81,723 - $101,651
-1,512 Reduced 0.23%
655,660 $42.2 Million
Q2 2018

Aug 14, 2018

SELL
$54.05 - $67.23 $11.2 Million - $14 Million
-207,785 Reduced 24.02%
657,172 $42.3 Million
Q1 2018

May 09, 2018

SELL
$46.55 - $57.38 $252,300 - $310,999
-5,420 Reduced 0.62%
864,957 $47.9 Million
Q4 2017

Feb 14, 2018

SELL
$46.22 - $51.77 $849,985 - $952,050
-18,390 Reduced 2.07%
870,377 $41.7 Million
Q3 2017

Nov 13, 2017

BUY
$47.8 - $53.63 $42.5 Million - $47.7 Million
888,767
888,767 $44.9 Million

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.84B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.